Viking Therapeutics (VKTX) Reports Q3 Loss of $0.08
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall St slumps as sharp tech losses put Nasdaq on course for correction
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 27.06 -0.91 (3.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.97 | 52 Week High | $5.17 | |||
| Open | $27.65 | 52 Week Low | $0.94 | |||
| Day High | $27.76 | P/E | N/A | |||
| Day Low | $26.69 | EPS | $0.00 | |||
| Volume | 551,002 | |||||
